Araştırma Makalesi
BibTex RIS Kaynak Göster

Materno-fetal characteristics, etiological factors and perinatal outcome in pregnancies with polyhydramnios

Yıl 2022, Cilt: 39 Sayı: 3, 817 - 821, 30.08.2022

Öz

This study aimed to evaluate materno-fetal characteristics, etiological factors and perinatal outcome in pregnancies with polyhydramnios. A total of 330 pregnancies diagnosed with polyhydramnios were included in this retrospective study conducted at a tertiary care clinic. Data on maternal age, obstetric characteristics, etiology of polyhydramnios, detailed prenatal ultrasonography findings on fetal anomaly, cesarean delivery and the adverse pregnancy outcomes were recorded. The polyhydramnios was idiopathic in 47.0% of cases, while the maternal diabetes (29.4%, gestational diabetes in 19.1%) and fetal conditions (23.6%) were responsible for the etiology in the remaining cases. The most common anomalies identified on prenatal ultrasonography were central nervous system (CNS) anomalies (29.5%, spina bifida in 12.8%), followed by the gastrointestinal system anomalies (11.5%, esophageal atresia in 6.4%). Cesarean delivery occurred in 38.2% of pregnancies, while adverse pregnancy outcomes were noted in 64.5% of pregnancies and included delivery of a neonate with congenital anomaly (36.6%), macrosomia (21.1%), preterm delivery (18.3%), perinatal mortality (13.1%) and pregnancy termination (10.8%). In conclusion, our findings revealed the polyhydramnios to be idiopathic in half of cases, and to be due to either maternal diabetes (gestational diabetes in particular) or fetal pathology (CNS and gastrointestinal anomalies, in particular) in the other half. Given the occurrence of adverse pregnancy outcomes in a considerable portion of pregnancies with polyhydramnios, our findings emphasize the vital role of intensive monitoring of the maternal-fetal condition in pregnancies with polyhydramnios. Meticulous diagnostic approach seems crucial for timely recognition of fetal anomalies via detailed imaging studies as well as the early recognition and strict control of gestational diabetes via close follow up, given the likelihood of erroneously diagnosed idiopathic polyhydramnios to challenge the implementation of proper management and appropriate counselling of patients.

Kaynakça

  • 1. Magann E, Chauhan S, Doherty D, Lutgendorf M, Magann I, Morrison JC. A review of idiopathic hydramnios and pregnancy outcomes. Obstet Gynecol Surv. 2007; 62(12): 795-802.
  • 2. Hwang DS, Bordoni B. Polyhydramnios. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022, PMID: 32965811.
  • 3. Matěcha J, Nováčková M. Idiopathic polyhydramnios. Ceska Gynekol. 2020; 85(6): 417-421.
  • 4. Biggio JR Jr, Wenstrom KD, Dubard MB, Cliver SP. Hydramnios prediction of adverse perinatal outcome. Obstet Gynecol. 1999; 94(5 Pt 1): 773-777.
  • 5. Pri-Paz S, Khalek N, Fuchs KM, Simpson LL. Maximal amniotic fluid index as a prognostic factor in pregnancies complicated by polyhydramnios. Ultrasound Obstet Gynecol. 2012; 39(6): 648-653.
  • 6. Aviram A, Salzer L, Hiersch L, Ashwal E, Golan G, Pardo J, et al. Association of isolated polyhydramnios at or beyond 34 weeks of gestation and pregnancy outcome. Obstet Gynecol. 2015; 125(4): 825-832.
  • 7. Bauserman M, Nathan R, Lokangaka A, McClure EM, Moore J, Ishoso D, et al. Polyhydramnios among women in a cluster-randomized trial of ultrasound during prenatal care within five low and low-middle income countries: a secondary analysis of the first look study. BMC Pregnancy Childbirth. 2019; 19(1): 258.
  • 8. Kyriacou C, Roper L, Mappouridou S, Lees C, Prior T. Contemporary experience of polyhydramnios: A single-centre experience. Australas J Ultrasound Med. 2021; 24(3): 137-142.
  • 9. Crimmins S, Mo C, Nassar Y, Kopelman JN, Turan OM. Polyhydramnios or Excessive Fetal Growth Are Markers for Abnormal Perinatal Outcome in Euglycemic Pregnancies. Am J Perinatol. 2018; 35(2): 140-145.
  • 10. Kollmann M, Voetsch J, Koidl C, Schest E, Haeusler M, Lang U, et al. Etiology and perinatal outcome of polyhydramnios. Ultraschall Med. 2014; 35(4): 350-356.
  • 11. Kornacki J, Adamczyk M, Wirstlein P, Osiński M, Wender-Ożegowska E. Polyhydramnios - frequency of congenital anomalies in relation to the value of the amniotic fluid index. Ginekol Pol. 2017; 88(8): 442-445.
  • 12. Pasquini L, Seravalli V, Sisti G, Battaglini C, Nepi F, Pelagalli R, et al. Prevalence of a positive TORCH and parvovirus B19 screening in pregnancies complicated by polyhydramnios. Prenat Diagn. 2016; 36(3): 290-293.
  • 13. Dashe JS, McIntire DD, Ramus RM, Santos-Ramos R, Twickler DM. Hydramnios: anomaly prevalence and sonographic detection. Obstet Gynecol. 2002; 100(1): 134-139.
  • 14. Abele H, Starz S, Hoopmann M, Yazdi B, Rall K, Kagan KO. Idiopathic polyhydramnios and postnatal abnormalities. Fetal Diagn Ther. 2012; 32(4): 251-255.
  • 15. Yefet E, Daniel-Spiegel E. Outcomes From Polyhydramnios With Normal Ultrasound. Pediatrics. 2016; 137(2): e20151948. 16. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358(19): 1991-2002.
  • 17. Yeung Leung T, Hung Suen SS. Manipulation of amniotic fluid volume: Oligohydramnios and polyhydramnios. In: Kliby MD, Oepkes D, Johnson A, editors. Fetal therapy Scientific Basis and Critical Appraisal of Clinical Benefits. New York: Cambridge Raven Press; 2013, p. 137-144.
  • 18. Ben-Chetrit A, Hochner-Celnikier D, Ron M, Yagel S. Hydramnios in the third trimester of pregnancy: a change in the distribution of accompanying fetal anomalies as a result of early ultrasonographic prenatal diagnosis. Am J Obstet Gynecol. 1990; 162(5): 1344-1345.
  • 19. Kleine RT, Bernardes LS, Carvalho MA, de Carvalho MH, Krebs VL, Francisco RP. Pregnancy outcomes in severe polyhydramnios: no increase in risk in patients needing amnioreduction for maternal pain or respiratory distress. J Matern Fetal Neonatal Med. 2016; 29(24): 4031-4034.
  • 20. Boito S, Crovetto F, Ischia B, Crippa BL, Fabietti I, Bedeschi MF, et al. Prenatal ultrasound factors and genetic disorders in pregnancies complicated by polyhydramnios. Prenat Diagn. 2016; 36(8): 726-730.
  • 21. Ogata AJ, Camano L, Brunoni D. Perinatal factors associated with neural tube defects (anencephaly [correction of anancephaly], spina bifida and encephalocele). Rev Paul Med. 1992; 110(4): 147-151.
  • 22. Fishel-Bartal M, Watad H, Hoffmann C, Achiron R, Barzilay E, Katorza E. Fetal brain MRI in polyhydramnios: is it justified? J Matern Fetal Neonatal Med. 2019; 32(23): 3986-3992.
  • 23. Shoham I, Wiznitzer A, Silberstein T, Fraser D, Holcberg G, Katz M, et al. Gestational diabetes complicated by hydramnios was not associated with increased risk of perinatal morbidity and mortality. Eur J Obstet Gynecol Reprod Biol. 2001; 100(1): 46-49.
  • 24. Desmedt EJ, Henry OA, Beischer NA. Polyhydramnios and associated maternal and fetal complications in singleton pregnancies. Br J Obstet Gynaecol. 1990; 97(12): 1115-1122.
  • 25. Zahn CM, Hankins GD, Yeomans ER. Karyotypic abnormalities and hydramnios. Role of amniocentesis. J Reprod Med. 1993; 38(8): 599-602.
  • 26. Nobile de Santis MS, Radaelli T, Taricco E, Bertini S, Cetin I. Excess of amniotic fluid: pathophysiology, correlated diseases and clinical management. Acta Biomed. 2004; 75(Suppl 1): 53-55
  • 27. Brady K, Polzin WJ, Kopelman JN, Read JA. Risk of chromosomal abnormalities in patients with idiopathic polyhydramnios. Obstet Gynecol. 1992; 79(2): 234-238.
  • 28. Fukami T, Goto M, Matsuoka S, Nishijima-Sorano S, Thyama A, Yamamoto H, et al. The relation between causes and onset time of polyhydramnios. Clin Exp Obstet Gynecol. 2017; 44(1): 113-115.
  • 29. Sagi-Dain L, Sagi S. Chromosomal aberrations in idiopathic polyhydramnios: A systematic review and meta-analysis. Eur J Med Genet. 2015; 58(8): 409-415.
  • 30. Suleiman A, Salim R. Mode of delivery among women admitted with polyhydramnios. J Obstet Gynaecol. 2017; 37(4): 454-458.
  • 31. Zeino S, Carbillon L, Pharisien I, Tigaizin A, Benchimol M, Murtada R, et al. Delivery outcomes of term pregnancy complicated by idiopathic polyhydramnios. J Gynecol Obstet Hum Reprod. 2017; 46(4): 349-354.
  • 32. Many A, Lazebnik N, Hill LM: The underlying cause of polyhydramnios determines prematurity. Prenat Diagn. 1996; 16(1): 55-57.
  • 33. Pilliod RA, Page JM, Burwick RM, Kaimal AJ, Cheng YW, Caughey AB. The risk of fetal death in nonanomalous pregnancies affected by polyhydramnios. Am J Obstet Gynecol. 2015; 213(3): 410.e1-6.
  • 34. Liu LL, Pang LH, Deng BY. Prenatal Diagnosis and Pregnancy Outcome Analysis of Polyhydramnios. Fetal Pediatr Pathol. 2016; 35(1): 21-28.
Yıl 2022, Cilt: 39 Sayı: 3, 817 - 821, 30.08.2022

Öz

Kaynakça

  • 1. Magann E, Chauhan S, Doherty D, Lutgendorf M, Magann I, Morrison JC. A review of idiopathic hydramnios and pregnancy outcomes. Obstet Gynecol Surv. 2007; 62(12): 795-802.
  • 2. Hwang DS, Bordoni B. Polyhydramnios. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022, PMID: 32965811.
  • 3. Matěcha J, Nováčková M. Idiopathic polyhydramnios. Ceska Gynekol. 2020; 85(6): 417-421.
  • 4. Biggio JR Jr, Wenstrom KD, Dubard MB, Cliver SP. Hydramnios prediction of adverse perinatal outcome. Obstet Gynecol. 1999; 94(5 Pt 1): 773-777.
  • 5. Pri-Paz S, Khalek N, Fuchs KM, Simpson LL. Maximal amniotic fluid index as a prognostic factor in pregnancies complicated by polyhydramnios. Ultrasound Obstet Gynecol. 2012; 39(6): 648-653.
  • 6. Aviram A, Salzer L, Hiersch L, Ashwal E, Golan G, Pardo J, et al. Association of isolated polyhydramnios at or beyond 34 weeks of gestation and pregnancy outcome. Obstet Gynecol. 2015; 125(4): 825-832.
  • 7. Bauserman M, Nathan R, Lokangaka A, McClure EM, Moore J, Ishoso D, et al. Polyhydramnios among women in a cluster-randomized trial of ultrasound during prenatal care within five low and low-middle income countries: a secondary analysis of the first look study. BMC Pregnancy Childbirth. 2019; 19(1): 258.
  • 8. Kyriacou C, Roper L, Mappouridou S, Lees C, Prior T. Contemporary experience of polyhydramnios: A single-centre experience. Australas J Ultrasound Med. 2021; 24(3): 137-142.
  • 9. Crimmins S, Mo C, Nassar Y, Kopelman JN, Turan OM. Polyhydramnios or Excessive Fetal Growth Are Markers for Abnormal Perinatal Outcome in Euglycemic Pregnancies. Am J Perinatol. 2018; 35(2): 140-145.
  • 10. Kollmann M, Voetsch J, Koidl C, Schest E, Haeusler M, Lang U, et al. Etiology and perinatal outcome of polyhydramnios. Ultraschall Med. 2014; 35(4): 350-356.
  • 11. Kornacki J, Adamczyk M, Wirstlein P, Osiński M, Wender-Ożegowska E. Polyhydramnios - frequency of congenital anomalies in relation to the value of the amniotic fluid index. Ginekol Pol. 2017; 88(8): 442-445.
  • 12. Pasquini L, Seravalli V, Sisti G, Battaglini C, Nepi F, Pelagalli R, et al. Prevalence of a positive TORCH and parvovirus B19 screening in pregnancies complicated by polyhydramnios. Prenat Diagn. 2016; 36(3): 290-293.
  • 13. Dashe JS, McIntire DD, Ramus RM, Santos-Ramos R, Twickler DM. Hydramnios: anomaly prevalence and sonographic detection. Obstet Gynecol. 2002; 100(1): 134-139.
  • 14. Abele H, Starz S, Hoopmann M, Yazdi B, Rall K, Kagan KO. Idiopathic polyhydramnios and postnatal abnormalities. Fetal Diagn Ther. 2012; 32(4): 251-255.
  • 15. Yefet E, Daniel-Spiegel E. Outcomes From Polyhydramnios With Normal Ultrasound. Pediatrics. 2016; 137(2): e20151948. 16. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358(19): 1991-2002.
  • 17. Yeung Leung T, Hung Suen SS. Manipulation of amniotic fluid volume: Oligohydramnios and polyhydramnios. In: Kliby MD, Oepkes D, Johnson A, editors. Fetal therapy Scientific Basis and Critical Appraisal of Clinical Benefits. New York: Cambridge Raven Press; 2013, p. 137-144.
  • 18. Ben-Chetrit A, Hochner-Celnikier D, Ron M, Yagel S. Hydramnios in the third trimester of pregnancy: a change in the distribution of accompanying fetal anomalies as a result of early ultrasonographic prenatal diagnosis. Am J Obstet Gynecol. 1990; 162(5): 1344-1345.
  • 19. Kleine RT, Bernardes LS, Carvalho MA, de Carvalho MH, Krebs VL, Francisco RP. Pregnancy outcomes in severe polyhydramnios: no increase in risk in patients needing amnioreduction for maternal pain or respiratory distress. J Matern Fetal Neonatal Med. 2016; 29(24): 4031-4034.
  • 20. Boito S, Crovetto F, Ischia B, Crippa BL, Fabietti I, Bedeschi MF, et al. Prenatal ultrasound factors and genetic disorders in pregnancies complicated by polyhydramnios. Prenat Diagn. 2016; 36(8): 726-730.
  • 21. Ogata AJ, Camano L, Brunoni D. Perinatal factors associated with neural tube defects (anencephaly [correction of anancephaly], spina bifida and encephalocele). Rev Paul Med. 1992; 110(4): 147-151.
  • 22. Fishel-Bartal M, Watad H, Hoffmann C, Achiron R, Barzilay E, Katorza E. Fetal brain MRI in polyhydramnios: is it justified? J Matern Fetal Neonatal Med. 2019; 32(23): 3986-3992.
  • 23. Shoham I, Wiznitzer A, Silberstein T, Fraser D, Holcberg G, Katz M, et al. Gestational diabetes complicated by hydramnios was not associated with increased risk of perinatal morbidity and mortality. Eur J Obstet Gynecol Reprod Biol. 2001; 100(1): 46-49.
  • 24. Desmedt EJ, Henry OA, Beischer NA. Polyhydramnios and associated maternal and fetal complications in singleton pregnancies. Br J Obstet Gynaecol. 1990; 97(12): 1115-1122.
  • 25. Zahn CM, Hankins GD, Yeomans ER. Karyotypic abnormalities and hydramnios. Role of amniocentesis. J Reprod Med. 1993; 38(8): 599-602.
  • 26. Nobile de Santis MS, Radaelli T, Taricco E, Bertini S, Cetin I. Excess of amniotic fluid: pathophysiology, correlated diseases and clinical management. Acta Biomed. 2004; 75(Suppl 1): 53-55
  • 27. Brady K, Polzin WJ, Kopelman JN, Read JA. Risk of chromosomal abnormalities in patients with idiopathic polyhydramnios. Obstet Gynecol. 1992; 79(2): 234-238.
  • 28. Fukami T, Goto M, Matsuoka S, Nishijima-Sorano S, Thyama A, Yamamoto H, et al. The relation between causes and onset time of polyhydramnios. Clin Exp Obstet Gynecol. 2017; 44(1): 113-115.
  • 29. Sagi-Dain L, Sagi S. Chromosomal aberrations in idiopathic polyhydramnios: A systematic review and meta-analysis. Eur J Med Genet. 2015; 58(8): 409-415.
  • 30. Suleiman A, Salim R. Mode of delivery among women admitted with polyhydramnios. J Obstet Gynaecol. 2017; 37(4): 454-458.
  • 31. Zeino S, Carbillon L, Pharisien I, Tigaizin A, Benchimol M, Murtada R, et al. Delivery outcomes of term pregnancy complicated by idiopathic polyhydramnios. J Gynecol Obstet Hum Reprod. 2017; 46(4): 349-354.
  • 32. Many A, Lazebnik N, Hill LM: The underlying cause of polyhydramnios determines prematurity. Prenat Diagn. 1996; 16(1): 55-57.
  • 33. Pilliod RA, Page JM, Burwick RM, Kaimal AJ, Cheng YW, Caughey AB. The risk of fetal death in nonanomalous pregnancies affected by polyhydramnios. Am J Obstet Gynecol. 2015; 213(3): 410.e1-6.
  • 34. Liu LL, Pang LH, Deng BY. Prenatal Diagnosis and Pregnancy Outcome Analysis of Polyhydramnios. Fetal Pediatr Pathol. 2016; 35(1): 21-28.
Toplam 33 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Clinical Research
Yazarlar

Özge Özdemir 0000-0003-2862-0802

Gökhan Bolluk 0000-0002-3506-6806

Ulaş Çoban 0000-0001-9760-7404

Kübra Bilirer 0000-0001-8204-2375

Erken Görünüm Tarihi 30 Ağustos 2022
Yayımlanma Tarihi 30 Ağustos 2022
Gönderilme Tarihi 11 Mayıs 2022
Kabul Tarihi 6 Haziran 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 39 Sayı: 3

Kaynak Göster

APA Özdemir, Ö., Bolluk, G., Çoban, U., Bilirer, K. (2022). Materno-fetal characteristics, etiological factors and perinatal outcome in pregnancies with polyhydramnios. Journal of Experimental and Clinical Medicine, 39(3), 817-821.
AMA Özdemir Ö, Bolluk G, Çoban U, Bilirer K. Materno-fetal characteristics, etiological factors and perinatal outcome in pregnancies with polyhydramnios. J. Exp. Clin. Med. Ağustos 2022;39(3):817-821.
Chicago Özdemir, Özge, Gökhan Bolluk, Ulaş Çoban, ve Kübra Bilirer. “Materno-Fetal Characteristics, Etiological Factors and Perinatal Outcome in Pregnancies With Polyhydramnios”. Journal of Experimental and Clinical Medicine 39, sy. 3 (Ağustos 2022): 817-21.
EndNote Özdemir Ö, Bolluk G, Çoban U, Bilirer K (01 Ağustos 2022) Materno-fetal characteristics, etiological factors and perinatal outcome in pregnancies with polyhydramnios. Journal of Experimental and Clinical Medicine 39 3 817–821.
IEEE Ö. Özdemir, G. Bolluk, U. Çoban, ve K. Bilirer, “Materno-fetal characteristics, etiological factors and perinatal outcome in pregnancies with polyhydramnios”, J. Exp. Clin. Med., c. 39, sy. 3, ss. 817–821, 2022.
ISNAD Özdemir, Özge vd. “Materno-Fetal Characteristics, Etiological Factors and Perinatal Outcome in Pregnancies With Polyhydramnios”. Journal of Experimental and Clinical Medicine 39/3 (Ağustos 2022), 817-821.
JAMA Özdemir Ö, Bolluk G, Çoban U, Bilirer K. Materno-fetal characteristics, etiological factors and perinatal outcome in pregnancies with polyhydramnios. J. Exp. Clin. Med. 2022;39:817–821.
MLA Özdemir, Özge vd. “Materno-Fetal Characteristics, Etiological Factors and Perinatal Outcome in Pregnancies With Polyhydramnios”. Journal of Experimental and Clinical Medicine, c. 39, sy. 3, 2022, ss. 817-21.
Vancouver Özdemir Ö, Bolluk G, Çoban U, Bilirer K. Materno-fetal characteristics, etiological factors and perinatal outcome in pregnancies with polyhydramnios. J. Exp. Clin. Med. 2022;39(3):817-21.